Dry Eye Disease

INDIANAPOLIS — Dry Eye Questionnaire-5 scores did not appear to align with ocular signs of dry eye in pediatric patients, highlighting the need for diagnostic tools tailored for children, according to a poster at Academy 2024.

The FDA has accepted the resubmitted new drug application for reproxalap, an investigational treatment for dry eye disease, and assigned a Prescription Drug User Fee Act date, according to a press release from Aldeyra Therapeutics.

INDIANAPOLIS — The oral supplement NutriTears significantly improved dry eye symptoms and tear volume compared with placebo in adults with dry eye disease, according to research presented at Academy 2024.

INDIANAPOLIS — In this Healio video, Kaleb Abbott, OD, MS, FAAO, assistant professor at University of Colorado School of Medicine, discusses three things optometrists should know about Vevye for dry eye.

Patients with dry eye disease experienced relief as early as 3 days after using Miebo, according to research presented at TFOS 2024.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Oculis CEO Riad Sherif, MD, provides a status report on OCS-01, OCS-02 and OCS-05 eye drops.

Brenting: v. To make bold and audacious deals in the eye care space.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Ranjan P. Malhotra, MD, FACS, discusses how Vevye, a higher-concentration formulation of cyclosporine, is “changing the landscape” in dry eye.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Tom Mitro about his career and impact in ophthalmology.

It is autumn on the North Coast. Longer nights lead to deeper insights as we contemplate the winter solstice. As usual, I am thinking dry eye. It is, as they say, how I roll.